3-V Biosciences' Grant

3-V Biosciences raised a round of funding on March 06, 2009. Investors include Qualifying Therapeutic Discovery Project.

3-V Biosciences is discovering and developing therapeutics that modulate key pathways in oncology and infectious diseases. In oncology, the company's lead candidate is a fatty acid synthase (FASN) inh…

Articles about 3-V Biosciences' Grant: